Search

DaVita Inc

Open

SectorHealthcare

182.18 -1.8

Overview

Share price change

24h

Current

Min

179.69

Max

185.6

Key metrics

By Trading Economics

Income

68M

343M

Sales

139M

3.6B

P/E

Sector Avg

15.543

50.373

EPS

4.02

Profit margin

9.657

Employees

78,000

EBITDA

98M

753M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+24.82% upside

Dividends

By Acuity

Next Earnings

1 lut 2027

Market Stats

By TradingEconomics

Market Cap

-3.2B

12B

Previous open

183.98

Previous close

182.18

DaVita Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 lis 2026, 21:12 UTC

DaVita Inc. is trading modestly lower in after-market hours, continuing a downward trend since Monday's close without significant recovery during the session.

30 paź 2026, 20:02 UTC

News
Social Media

DaVita Inc. is under pressure after Bronstein, Gewirtz & Grossman, LLC announced an investigation into potential claims on behalf of investors.

29 paź 2026, 23:02 UTC

Social Media
News

DaVita reports Q3 earnings of $3.82 per share and $3.58 billion in revenue, but shares fall sharply after disappointing full-year guidance and a $62 million impairment charge.

28 paź 2026, 23:02 UTC

DaVita Inc. is declining in after-market trading, falling significantly below its 20-day moving average and near the lower end of its one-month trading range.

27 paź 2026, 20:07 UTC

News

DaVita Inc. is under investigation by Bronstein, Gewirtz & Grossman, LLC, following a U.S. Department of Health announcement affecting the dialysis market.

26 paź 2026, 19:36 UTC

DaVita Inc shares are trading modestly higher, remaining above their 20-day moving average and near the upper end of their one-month range.

22 paź 2026, 20:02 UTC

DaVita Inc shares are sharply higher, breaking from a recent trend of higher daily closes and diverging from prior upward momentum.

21 paź 2026, 20:07 UTC

News

DaVita Inc reaffirmed as a "Buy" with a price target of $265 in a report from DBAB, which sees no significant changes to the HHS kidney care plan.

20 paź 2026, 23:06 UTC

DaVita Inc shares traded modestly lower in after-market hours, continuing a downward trend from Tuesday's close and remaining below its 20-day moving average.

16 paź 2026, 19:34 UTC

DaVita Inc shares are declining amid significant market downturns, influenced by stronger-than-expected U.S. industrial production and ongoing inflation concerns.

15 paź 2026, 20:02 UTC

News

DaVita Inc presents seven studies at ASN Kidney Week 2026, showcasing advancements in kidney care and emphasizing its commitment to clinical research.

14 paź 2026, 20:41 UTC

DaVita Inc. saw a modest decline during after-market hours on Wednesday, moving to a loss of nearly one percent as it trades near its one-month range low.

8 paź 2026, 20:07 UTC

DaVita Inc's shares are trading higher, recovering slightly from an earlier low, but remain below their 20-day moving average.

7 paź 2026, 20:08 UTC

DaVita Inc. shares fell sharply amid broader market weakness, retreating from a morning rise and closing down significantly since Tuesday's close.

6 paź 2026, 21:10 UTC

DaVita Inc. has declined sharply in after-market trading, reaching its lowest point of the day and falling below its 20-day moving average.

2 paź 2026, 20:07 UTC

DaVita Inc. shares are higher, having peaked early in the session, and remain above their opening level despite being near the lower end of their one-month range.

1 paź 2026, 20:07 UTC

DaVita Inc. is advancing, reflecting a modest increase since Wednesday's close, despite pulling back from an earlier session high.

28 wrz 2026, 20:07 UTC

DaVita Inc's shares fell amid rising crude oil prices and inflation concerns, following a broader market decline that has affected major technology stocks.

25 wrz 2026, 20:07 UTC

DaVita Inc. is advancing, reflecting broader market gains, despite earlier pulling back from a session high and remaining below its 20-day moving average.

24 wrz 2026, 20:01 UTC

DaVita Inc shares fell, marking a shift in momentum after a streak of higher daily closes in recent sessions.

18 wrz 2026, 19:46 UTC

DaVita Inc is modestly higher, recovering from an initial decline, and is currently above its 20-day moving average within its one-month trading range.

17 wrz 2026, 22:31 UTC

DaVita Inc is trading higher in after-market hours, reaching a peak above its 20-day moving average and positioned near the midpoint of its one-month range.

16 wrz 2026, 20:10 UTC

DaVita Inc has gained ground during Wednesday's trading session, reaching a peak earlier and remaining significantly above its 20-day moving average.

15 wrz 2026, 23:56 UTC

DaVita Inc shares are lower in after-market trading amid negative sentiment following a sharp decline in the NY Empire State Manufacturing Index.

14 wrz 2026, 23:41 UTC

DaVita Inc. shares declined in after-market trading, reflecting broader market trends amid rising crude oil prices and inflationary concerns.

11 wrz 2026, 20:51 UTC

DaVita Inc shares are higher in after-market hours, though no specific news explains the movement. The stock remains above its 20-day moving average.

9 wrz 2026, 20:07 UTC

DaVita Inc. is higher in Wednesday trading, recovering from an early decline. The stock remains above its 20-day moving average and near a one-month peak.

8 wrz 2026, 20:04 UTC

DaVita Inc is trading lower today amid a decline in the Health Care Services sub-sector and broader market weakness. No specific company news was identified.

3 wrz 2026, 20:07 UTC

DaVita Inc shares are higher during Thursday's session, maintaining an upward trend since Wednesday's close amid a broader market rally and declining Treasury yields.

31 sie 2026, 20:02 UTC

DaVita Inc's shares are lower today, breaking a trend of higher closes. Broader market conditions may be influencing the decline amid rising interest rate expectations.

Peer Comparison

Price change

DaVita Inc Forecast

Price Target

By TipRanks

24.82% upside

12 Months Forecast

Average 231.833 USD  24.82%

High 287 USD

Low 180 USD

Based on 6 Wall Street analysts offering 12 month price targets forDaVita Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

3

Buy

2

Hold

1

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
help-icon Live chat